HOUSTON – (Aug. 29, 2022) – A Sept. 9 event from Rice University’s Baker Institute for Public Policy will examine misinformation surrounding stem cell research and regenerative medicine.
Stem cells have been widely marketed to the public for their regenerative properties and their promise for revolutionizing medicine, but often with claims that far exceed the known benefits. At best, the procedures are largely ineffective, and at worst, patients are exposed to severe health complications, said Kirstin Matthews, fellow in science and technology policy at the Baker Institute.
At this event, a panel of experts from various disciplines will discuss the clinical and promotional landscape of stem cell-based interventions. The panelists will share studies on misinformation perpetuated by less reputable providers, ways of correcting misinformation and policy approaches to help lead patients to more informed decision-making.
What: Baker Institute event, “Regenerative Medicine: Highlighting and Correction Misinformation.”
Who: Zubin Master, nonresident scholar at the Baker Institute and associate professor of biomedical ethics at the Mayo Clinic’s Biomedical Ethics Research Program and Center for Regenerative Medicine, and Emily Vraga, the Don and Carole Larson Professor in Health Communication at the University of Minnesota. Emerson Perin, medical director at the Texas Heart Institute and director of its Center for Clinical Research and Stem Cell Center, will moderate and Matthews will provide welcome remarks.
When: Friday, Sept. 9, 7:30-9 a.m.
This event is part of an annual policy lecture series co-sponsored by the Baker Institute Center for Health and Biosciences and the Texas Heart Institute, with support from the George and Mary Josephine Hamman Foundation.